The lawsuit alleges that Operation Metro Surge violates federal law because it’s arbitrary and capricious, since it says ...
Positioned to increase depth of Vafseo prescribing entering 2026 with access to approximately 275,000 patients First patient dosed in ...
Biogen Inc. (Nasdaq: BIIB) today announced the European Commission (EC) has granted marketing authorization for a high dose ...
The Macomb Daily on MSN
Clinton Township to consider 21 and over restriction on kratom
Users swear by kratom for lifting mood and boosting energy, but there are many safety issues and questions about ...
Federal Reserve Chair Jerome Powell says the Department of Justice has served the central bank with subpoenas and threatened ...
Renowned Nigerian author Chimamanda Adichie has demanded accountability from a private hospital in Lagos, accusing it of ...
Based on the topline results from HERIZON-GEA-01, Jazz plans to submit a supplemental Biologics License Application in 1H-2026 for zanidatamab in the U.S. as first-line treatment for HER2+ locally ...
Opinion
COMMENTARY: Nicolás Maduro is not just a corrupt leader. He’s also a direct threat to US security
Venezuelan President Nicolás Maduro's removal from power following his capture in a U.S. military operation rests on a mix of long-standing criminal cases against him, nonrecognition of his presidency ...
Milestone marks progress against AbbVie's previously announced commitment to invest more than $10 billion of capital in the U.S. over the next decade to broadly support ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
The 'spirit of limited, efficient government' is a value that will help Idaho 'navigate the budget pressures before us,' the ...
The FDA has issued a complete response letter for the partners’ application in EBV+PTLD, marking the agency’s second snub of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results